By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bellicum Pharmaceuticals, Inc. 

2 Greenway Plaza
Suite 1380
Houston  Texas  77046  U.S.A.
Phone: 713-798-8670 Fax: 713-798-4950


SEARCH JOBS



Segment
Vaccines





Company News
Cancer Biotech Bellicum Pharmaceuticals, Inc. Files For $115 Million IPO 11/19/2014 6:21:05 AM
Bellicum Pharmaceuticals, Inc. Appoints Reid Huber, Ph.D. To Board Of Directors 11/17/2014 12:05:13 PM
Ariad Pharmaceuticals, Inc. (ARIA), Bellicum Pharmaceuticals, Inc. Revise Pact; Ariad Will Receive $50 Million In Three Installments 10/6/2014 6:02:39 AM
Houston Biotech Bellicum Pharmaceuticals, Inc. Nabs $55 Million 8/27/2014 6:32:36 AM
Bellicum Pharmaceuticals, Inc. To Present At Jefferies and Co. 2014 Global Healthcare Conference In New York City 6/3/2014 7:11:03 AM
Bellicum Pharmaceuticals, Inc. To Present At Jefferies and Co. 2014 Global Healthcare Conference In New York City 6/3/2014 6:55:26 AM
Bellicum Pharmaceuticals, Inc. Hauls In $34.4 Million Series B Financing 1/7/2014 6:46:04 AM
Bellicum Pharmaceuticals, Inc. Initiates Clinical Trial With Novel Controlled Dendritic Cell Immunotherapy in Metastatic Castrate Resistant Prostate Cancer 7/9/2013 9:43:52 AM
Bellicum Pharmaceuticals, Inc. Selects DATATRAK International, Inc. (DATA) Solution for Drug Program 9/12/2012 10:46:37 AM
Bellicum Pharmaceuticals, Inc. Appoints Baylor College of Medicine's David M. Spencer as Chief Scientific Officer 4/12/2012 10:28:11 AM
123
//-->